Losartan Potassium
Summary of product characteristics
Effective Time
20221018
Version
10
Spl Product Data Elements
Losartan Potassium Losartan Potassium LOSARTAN POTASSIUM LOSARTAN HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM STARCH GLYCOLATE TYPE A POTATO TALC TITANIUM DIOXIDE SILICON DIOXIDE CELLULOSE, MICROCRYSTALLINE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED STARCH, CORN POLYETHYLENE GLYCOL, UNSPECIFIED WHITE TO OFF-WHITE CAPSULE Z;2 Losartan Potassium Losartan Potassium LOSARTAN POTASSIUM LOSARTAN HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM STARCH GLYCOLATE TYPE A POTATO TALC TITANIUM DIOXIDE SILICON DIOXIDE CELLULOSE, MICROCRYSTALLINE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED STARCH, CORN POLYETHYLENE GLYCOL, UNSPECIFIED WHITE TO OFF-WHITE CAPSULE Z16 Losartan Potassium Losartan Potassium LOSARTAN POTASSIUM LOSARTAN HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM STARCH GLYCOLATE TYPE A POTATO TALC TITANIUM DIOXIDE SILICON DIOXIDE CELLULOSE, MICROCRYSTALLINE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED STARCH, CORN POLYETHYLENE GLYCOL, UNSPECIFIED WHITE TO OFF-WHITE CAPSULE Z18
Application Number
ANDA078243
Brand Name
Losartan Potassium
Generic Name
Losartan Potassium
Product Ndc
65841-729
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-729-01 Losartan Potassium Tablets USP, 25 mg Rx Only 100 Tablets Zydus NDC 65841-730-01 Losartan Potassium Tablets USP, 50 mg Rx Only 100 Tablets Zydus NDC 65841-731-01 Losartan Potassium Tablets USP, 100 mg Rx Only 100 Tablets Zydus 25 mg 50 mg 100 mg
380 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.